An observational study in Endometriosis and Endometriosis Colon, sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Active, not recruiting at 1 site in Italy. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.
Sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 106 studies in Endometriosis with a site in Italy — 28 open to participants now, 34 under way, none of them phase 3. Endometriosis · Italy.
Among the 106 studies in Endometriosis with a site in Italy, this one is the 60th largest by planned enrollment of the 61 observational ones that give a count, is one of 6 that started in 2026, is one of 61 observational ones, reaches primary completion later than 25 of the 33 other live ones, and was the 106th registered.
924 studies on the registry are indexed under Endometriosis; 269 are open to participants now.
Browse Endometriosis studies →28 of the 106 studies in Endometriosis with a site in Italy are open now. Recruiting first, the newest first:
Casa di Cura Dott. Pederzoli · Sites in Italy
Ages 18+ · Women only
IRCCS Azienda Ospedaliero-Universitaria di Bologna · Sites in Italy
Ages 18–40 · Women only
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Sites in Italy
Ages 18–50 · Women only
Casa di Cura Dott. Pederzoli · Sites in Italy
Ages 18–50 · Women only
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Sites in Italy
Ages 18–39 · Women only
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 180 Endometriosis studies recruiting now, 52 (29%) set no upper age limit and 126 (70%) stop at 75 or younger; 18 take children under 18; 39 take healthy volunteers.
This study: 18 Years and older · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
106 studies; the count open now beside each. This study's row is marked.
First in 2004; this study’s year is marked. 6 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 132 across 351 observational studies indexed under Endometriosis.
Median enrollment 84 across the 45 interventional studies, 200 across the 61 observational. Of the 51 that completed or were terminated, 5 (10%) have results posted.
This tab as a report to print or save as PDF → With an account.
13 of 106 have an industry lead sponsor. The 10 most frequent:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is the lead sponsor of 953 studies on the registry; 541 are open to participants now.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS has 6 studies filed under Endometriosis — fewer than ten, so there is no comparison to draw.
3 of the studies in Endometriosis with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07260669Gesynta Pharma ABA Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis | 2027-06 |
| NCT07944560Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoDevelopment of dEep EndometrioSis Following Acute haemoPerITonEum | 2027-06 |
| NCT06781398IRCCS Azienda Ospedaliero-Universitaria di BolognaRobotic Surgery in the Treatment of Deep Endometriosis: Da Vinci Vs HUGO RAS Comparison | 2027-07 |
Add all 3 to your calendar (.ics) → With an account.
Among the 106 studies in Endometriosis with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The REMEDE study, a single-center retrospective and prospective observational study conducted at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, aims to evaluate the validity of laparoscopic intraoperative ultrasound (IOUS) in measuring rectosigmoid deep infiltrating endometriosis nodules. The primary objective is to determine the equivalence and agreement between nodule dimensions (expressed in millimeters) measured via postoperative histological examination-considered the gold standard-preoperative transvaginal ultrasound (TVUS), and laparoscopic intraoperative ultrasound performed after bowel mobilization (IOUS). Secondary objectives include analyzing potential systematic bias (overestimation or underestimation) of the ultrasound methods compared to histology, evaluating direct agreement between TVUS and IOUS, and conducting an exploratory analysis to verify whether factors such as lesion location, presence of adhesions, and nodule size influence measurement accuracy. The study plans to enroll a total of 20 adult female patients undergoing laparoscopic surgery for posterior compartment endometriosis with rectosigmoid involvement. The primary endpoint will be statistically analyzed using the Two One-Sided Tests (TOST) approach to test the equivalence of paired differences based on predefined margins, supported by descriptive analyses using the Intraclass Correlation Coefficient (ICC) and Bland-Altman methods.
Adult women undergoing laparoscopic surgery for posterior compartment endometriosis with rectosigmoid involvement.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All patients will undergo standardized preoperative transvaginal ultrasound (TVUS) by expert operators to record nodule location, distance from the anal verge, and dimensions in three planes (longitudinal extension, transverse diameter, and depth of infiltration) in millimeters. During laparoscopic surgery, following complete rectosigmoid mobilization and lesion exposure, intraoperative ultrasound (IOUS) will be performed using an intracorporeal linear probe to measure the same three dimensions. The surgical specimen will then undergo standardized histological evaluation to assess maximum nodule thickness, depth of bowel wall infiltration, and associated fibrosis. Histological thickness measurement will serve as the gold standard for concordance analysis with TVUS and IOUS findings.
Also known as: bowel resection
Equivalence between rectosigmoid endometriosis nodule dimensions.
To evaluate the equivalence between rectosigmoid endometriosis nodule dimensions (mm) measured by TVUS and IOUS compared to the histological gold standard.
Time frame: 6 months
The presence of systematic bias
To evaluate the presence of systematic bias (overestimation/underestimation) of TVUS and IOUS measurements compared to histology
Time frame: 6 months
The agreement between TVUS and IOUS
To assess the agreement between TVUS and IOUS
Time frame: 6 months
Potential influence of nodule location.
To conduct an exploratory analysis of the potential influence of nodule location (rectum vs. sigmoid), presence of bowel adhesions, and nodule size on the obtained measurements.
Time frame: 6 months
Started Sep 2026 (actual). Primary completion is estimated for Dec 2027, 14 months after the start.
Of 157 non-industry observational studies under Endometriosis, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 48. This study's planned 14 months is below that.
Counting every sponsor, half of 184 studies reached it within 30 months; a quarter within 14 and three quarters within 47.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS →